Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer.
Yamamoto K, Tateishi K, Kudo Y, Hoshikawa M, Tanaka M, Nakatsuka T, Fujiwara H, Miyabayashi K, Takahashi R, Tanaka Y, Ijichi H, Nakai Y, Isayama H, Morishita Y, Aoki T, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M, Koike K.
Yamamoto K, et al. Among authors: tanaka m, tanaka y.
Oncotarget. 2016 Sep 20;7(38):61469-61484. doi: 10.18632/oncotarget.11129.
Oncotarget. 2016.
PMID: 27528027
Free PMC article.